V-BID Update: Rising Costs and Coverage Gaps Shape Access and Patient Decisions

In this Issue:

• $0 Medication Costs Linked to Improved Hypertension Adherence
• GLP-1 Coverage Support High, but Cost and Uncertainty Limit Access
• Patients Willing to Use Lower-Cost Treatments to Keep Weight Off
• Medicaid Expansion Linked to Long-Term Financial Gains for Enrollees
• UnitedHealthcare Plans Major Reduction in Prior Authorization Requirements
• Health Care Costs Shape Voter Priorities

$0 Medication Costs Linked to Improved Hypertension Adherence

A study published in the Journal of the American Heart Association analyzes how out-of-pocket medication costs impact adherence among veterans with newly diagnosed hypertension. The analysis finds that eliminating patient costs is associated with better medication use, while even modest costs can reduce adherence. Specifically, $0 out-of-pocket costs were associated with lower odds of nonadherence and medication discontinuation, while small copays (about $8/month) were linked to higher rates of both.

GLP-1 Coverage Support High, but Cost and Uncertainty Limit Access

A survey analysis of consumer views and use of GLP-1 medications among privately insured adults shows broad support for insurance coverage, but highlight gaps in awareness and affordability that limit access and sustained use. About 50% of respondents did not know if GLP-1 drugs were covered, and among those who used them, 35% stopped treatment, with 40% citing affordability and about 14% citing lack of coverage as key reasons.

Patients Willing to Use Lower-Cost Treatments to Keep Weight Off, Allowing More Access to GLP-1s

A study published in The American Journal of Managed Care examines patient perspectives on using lower-cost alternatives to maintain weight loss after initial GLP-1 treatment. 83% of respondents support lower-cost maintenance options and nearly 90% support transitions to lower-cost alternatives if it would expand access to GLP-1 therapies. Respondents also emphasized the importance of broad coverage for effective lower-cost treatments while citing concerns about adverse effects and weight regain if GLP-1 medications are reduced or stopped.

Medicaid Expansion Linked to Long-Term Financial Gains for Enrollees

A study from the U-M IHPI found that expanded Medicaid coverage is associated with sustained improvements in financial stability, particularly through reduced medical debt and improved credit outcomes. Enrollees experienced up to a 75% reduction in medical debt sent to collections and continued declines for at least 7 years after enrollment. The study also found significant improvements in credit scores, with a 30% to 50% reduction in subprime scores, indicating broader gains in financial health.

UnitedHealthcare Plans Major Reduction in Prior Authorization Requirements

UnitedHealthcare announced a plan to reduce prior authorization requirements, highlighting a shift toward simplifying access to care by removing administrative barriers that can delay treatment. By the end of 2026, the insurer will eliminate prior authorization for about 30% of currently affected services, including select outpatient surgeries, diagnostic tests, and therapies. The company notes that prior authorization applies to about 2% of its services, with roughly 92% of requests approved within 24 hours.

Health Care Costs Shape Voter Priorities

A poll from United States of Care and Morning Consult analyzes public attitudes on health care affordability ahead of the 2026 midterm elections. The findings show that health care costs are a major political and financial concern for U.S. adults. Overall, 76% of respondents said a candidate’s position on health care costs is important in deciding their vote, while 69% said Congress should act to ensure affordable care, even if it requires regulating health care companies. The poll also found that 71% of people believe health care costs are unaffordable for individuals and families.

Missed an Issue of Our Newsletter?

You can always find previous editions of our weekly newsletters on our website here.